Archive - April 2025
Déjà Vu: OPDP Again Targets Provider Branded Website of Accelerated Approval Drug in Second Untitled Letter of 2025
Opinion: Government word search is killing my cutting-edge research
FDA Announces New Policy on Advisory Committee Members
Balancing Cost Control with Innovation Amidst Tariffs
ASCA 2024 Performance Update: Can ASCA Improve Submission Predictability?
Opinion: The ‘yes, and’ approach to dementia care
Expanding Immune Response Testing to Support Vaccine Development
Inside Lonza CHI’s Innovation Engine: Future-Ready Capsules for Complex Drugs